These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 7506151)
81. Nimesulide. New clinical opportunities. Tognella S Drugs; 1993; 46 Suppl 1():275-6. PubMed ID: 7506189 [No Abstract] [Full Text] [Related]
82. Pharmacokinetic variations of nimesulide in mongrel dogs according to age. Guillé PG; Guillé PBE; Espinosa RL; Juárez-Olguín H; Álvarez GR; Brisuela ON; Portugal CM; Garcidueñas CL; Rosales SRE; Luna JMA; Medina AR; Pacheco CJL Pharmazie; 2019 Dec; 74(12):728-731. PubMed ID: 31907111 [TBL] [Abstract][Full Text] [Related]
83. Facing the pain of dysmenorrhoea. Gould D Nurs Stand; 1994 Jul 13-9; 8(42):25-8. PubMed ID: 8080766 [No Abstract] [Full Text] [Related]
84. Nimesulide: a multifactorial therapeutic approach to the inflammatory process? A 7-year clinical experience. Proceedings of an international congress, Berlin, October 1-3, 1992. Drugs; 1993; 46 Suppl 1():1-283. PubMed ID: 7506141 [No Abstract] [Full Text] [Related]
85. Too much effectiveness from a herbal drug. Vannacci A; Lapi F; Baronti R; Gallo E; Gori L; Mugelli A; Firenzuoli F Br J Clin Pharmacol; 2009 Apr; 67(4):473-4. PubMed ID: 19371323 [No Abstract] [Full Text] [Related]
86. Increased activity of lysosomal enzymes in plasma of dysmenorrhoeic women. Strömberg P; Gustavii B; Isaksson A; Hultberg B Lancet; 1982 Jul; 2(8290):158-9. PubMed ID: 6123869 [No Abstract] [Full Text] [Related]
87. Clinical pharmacokinetics of nimesulide. Bernareggi A Clin Pharmacokinet; 1998 Oct; 35(4):247-74. PubMed ID: 9812177 [TBL] [Abstract][Full Text] [Related]
88. The pharmacokinetic profile of nimesulide in healthy volunteers. Bernareggi A Drugs; 1993; 46 Suppl 1():64-72. PubMed ID: 7506196 [TBL] [Abstract][Full Text] [Related]
89. Nimesulide in dysmenorrhoea. Pulkkinen M Drugs; 1993; 46 Suppl 1():129-33. PubMed ID: 7506151 [TBL] [Abstract][Full Text] [Related]
90. Alterations in intrauterine pressure, menstrual fluid prostaglandin F levels, and pain in dysmenorrheic women treated with nimesulide. Pulkkinen MO J Clin Pharmacol; 1987 Jan; 27(1):65-9. PubMed ID: 3680556 [TBL] [Abstract][Full Text] [Related]
91. Analysis of uterine contractility after administration of the non-steroidal anti-inflammatory drug nimesulide. Pulkkinen M; Monti T; Macciocchi A Acta Obstet Gynecol Scand; 1992 Apr; 71(3):181-5. PubMed ID: 1317639 [TBL] [Abstract][Full Text] [Related]
92. The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study. Pirhonen J; Pulkkinen M Acta Obstet Gynecol Scand; 1995 Aug; 74(7):549-53. PubMed ID: 7618455 [TBL] [Abstract][Full Text] [Related]
93. Distribution of oral nimesulide in female genital tissues. Pulkkinen MO; Vuento M; Macciocchi A; Monti T Biopharm Drug Dispos; 1991 Mar; 12(2):113-7. PubMed ID: 2031992 [TBL] [Abstract][Full Text] [Related]
94. The intra-amniotic pressure. COREN RL; CSAPO AI Am J Obstet Gynecol; 1963 Feb; 85():470-83. PubMed ID: 14023021 [No Abstract] [Full Text] [Related]
95. Nimesulide inhibits platelet-activating factor synthesis in activated human neutrophils. Verhoeven AJ; Tool AT; Kuijpers TW; Roos D Drugs; 1993; 46 Suppl 1():52-8. PubMed ID: 7506195 [TBL] [Abstract][Full Text] [Related]